Jove
Visualize
Contact Us

Related Concept Videos

Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Blunt Chest Wall Trauma Leading to Sudden Cardiac Arrest.

JACC. Case reports·2024
Same author

[Foreign body stories].

Therapeutische Umschau. Revue therapeutique·2008
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Comorbidity in heart failure].

Fritz Widmer1

  • 1Medizinische Klinik, Kardiologie, Kantonsspital Münsterlingen. Fritz.Widmer@stgag.ch

Therapeutische Umschau. Revue Therapeutique
|January 29, 2011
PubMed
Summary
This summary is machine-generated.

Managing noncardiac comorbidities like renal insufficiency and diabetes is crucial for heart failure patients, significantly impacting hospitalizations and mortality. Addressing these conditions improves patient outcomes and quality of life.

Related Experiment Videos

Area of Science:

  • Cardiology
  • Nephrology
  • Endocrinology
  • Pulmonology

Context:

  • Noncardiac comorbidities are prevalent in patients with congestive heart failure (CHF).
  • These comorbidities significantly influence hospitalization rates and overall mortality.
  • Key comorbidities include renal insufficiency, diabetes mellitus, chronic obstructive pulmonary disease (COPD), sleep disorders (apnea), and anemia.

Purpose:

  • To highlight the importance of recognizing and managing noncardiac comorbidities in CHF.
  • To discuss the impact of specific comorbidities on heart failure prognosis and treatment.
  • To outline therapeutic considerations for managing common comorbidities in heart failure.

Summary:

  • Renal insufficiency is a major predictor of mortality in heart failure patients.
  • Diabetes mellitus is an independent risk factor for heart failure, with specific drug considerations.
  • COPD management in heart failure may involve underuse of beta-blockers; sleep disorders require CPAP therapy; anemia treatment remains debated.
  • Managing these complex comorbidities requires a multidisciplinary approach, potentially involving heart failure nurses.

Impact:

  • Effective management of comorbidities can reduce hospitalizations and mortality in heart failure.
  • Optimizing treatment for conditions like renal insufficiency, diabetes, and COPD improves heart failure outcomes.
  • Addressing sleep disorders and anemia can enhance quality of life and potentially reduce adverse events.